C Blatrix

Institut National de la Transfusion Sanguine

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

M. Steinbuch

Eindhoven University of Technology

Soulier Jp

Institut National de la Transfusion Sanguine

R Audran

University Hospital of Lausanne

J P Soulier

Pennsylvania State University

Vic-Dupont

Clinique Claude-Bernard

F Josso

Institut National de la Transfusion Sanguine

Pierre-Bourgeois

J. Drouet

Pitié-Salpêtrière Hospital

Tillement Jp

Hôpital Intercommunal de Créteil

P Amouch

Institut National de la Transfusion Sanguine

Cooperative Institutions

Institut National de la Transfusion Sanguine

Inserm

Sorbonne Université

Hôpital Intercommunal de Créteil

Centre National de la Recherche Scientifique

Université Paris Cité

Hôpital Necker-Enfants Malades

Hôpital Saint-Antoine

Pitié-Salpêtrière Hospital

Bicêtre Hospital

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

[Diuretic treatment of arterial hypertension. Value of potassium sparing].

PubMed (1972)

C Blatrix

Value (mathematics)

Source

Cite

Citations (0)

Clinical pharmacology of flurbiprofen: a novel inhibitor of platelet aggregation

Current Medical Research and Opinion (1977)

J.J. Thebault G. Lagrue C Blatrix L. Cheynier R Cluzan

Studies are reviewed of the inhibitory effect of flurbiprofen, given in doses ranging from 50 mg to 200 mg per day for 1 week, on platelet aggregation measured by biological tests (adenosine diphosphate and collagen methods). Flurbiprofen at doses of 50 mg and 100 mg daily had a peak time of action of between 1 and 2 hours, the effects usually disappearing after 24 hours, and 100 mg flurbiprofen caused a similar decrease in platelet aggregation to 1 g aspirin daily. In a clinical study of 72 patients with chronic glomerulonephritis treated with doses of flurbiprofen up to 200 daily there was a significant correlation between the parameters of aggregation measured and treatment, and between proteinuria and adenosine disphosphate aggregation when the flurbiprofen dose did not exceed 100 mg daily.

Flurbiprofen

Adenosine diphosphate

10.1185/03007997709108990

Cite

Citations (13)

[Primary osteochondroma of the lung; hamartoma].

PubMed (1953)

R Moreau Pierre-Bourgeois Vic-Dupont C Blatrix J Brizard

Hamartoma

Source

Cite

Citations (0)